The scope of this market defines the Acinetobacter pneumonia therapeutics as the complete spectrum of pharmaceutical and therapeutic solutions designed to address the disease resulting from the Acinetobacter genus of bacterial pneumonia.

Actinic keratosis defined as precancerous cutaneous lesion which results from prolonged exposure to UV radiation, and manifests clinically by the presence of rough, scaly skin lesions predominantly on sun exposed areas. These lesions are usually located on the face, ears, neck, scalp, and the dorsa of hands and may prove carcinogenic especially the squamous cell kind. The Actinic Keratosis market includes diagnostic procedures, cure and prevention measures that can be used for AK, those therapies involve using topical treatments, cryotherapy, photodynamic therapy, and lasers.

ABSSSI means Acute Bacterial Skin and Skin Structure Infection, that is, bacterial infection that develops on the skin and in the immediate subcutaneous tissue. These are cellulitis, wound infection, major abscesses and necrotising fasciitis which is a serious skin infection. ABSSSI is mostly due to gram-positive pathogens and is most frequently associated with Staphylococcus aureus and the Streptococci group especially those generators of methicillin –resistant Staphylococcus aureus (MRSA).

The phobic disorders treatment market consists all treatments and medications which are employed for treating phobic disorders, which are defined by the severe and unjustified fear of definite objects, situations, or activities. This market consists of different approaches like psychotherapy which include CBT, exposure therapy or pharmacological treatments which are SSRIs, benzodiazepines.